Duke University immunotherapy shows promise

DUKE UNIVERSITY

Colon cancer is the second leading cause of cancer death in the United States – and the leading cause of cancer death for men under the age of 50. A Duke University immunotherapy trial is showing promise as an alternative to chemotherapy.

As colon cancer rates among people younger than 50 skyrocket, a new clinical trial that uses immunotherapy, rather than physically demanding chemotherapy, is yielding promising results…